M306T
Category 4 — Stable Fold, Function DisruptedConflictingCytoplasmic · predictedEditorialMethionine → Threonine at position 306 in N-terminal cytoplasmic domain. ClinVar Conflicting including monogenic diabetes + WFS1 spectrum. AlphaMissense 0.14 (below threshold) — AM under-call. DynaMut2 ΔΔG -0.03 (neutral).
Interactive 3D Structure
Bond changes · DynaMut2 interaction analysis
| Interaction type | Wild-type partner | Mutant partner | Status |
|---|---|---|---|
| Hydrogen bond | Y302 | Y302 | Preserved |
| Hydrogen bond | L303 | — | Lost |
| Hydrogen bond | A310 | A310 | Preserved |
| Polar contact | Y302 | Y302 | Preserved |
| Polar contact | L303 | L303 | Preserved |
| Polar contact | I304 | I304 | Preserved |
| Polar contact | A310 | A310 | Preserved |
| Van der Waals | Y302 | Y302 | Preserved |
| Van der Waals | I304 | I304 | Preserved |
| Hydrophobic | Y302 | — | Lost |
Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.
Computational Predictions
Clinical Evidence
Observed in the general population.
Structural Context
Position 306 near TM1 boundary. Neighbors: ASP305 (2.5 Å), ALA307 (2.5 Å — partner of S308C!), LEU303 (3.9 Å).
M306T near the S308C variant region. Loss of methionine-specific chemistry + introduced polarity. AM 0.14 under-call; multi-phenotype confirms.
Druggability Assessment
Mechanism: lost methionine chemistry near TM1 boundary. Therapeutic: same 305-308 microregion as S308C.
Why this matters
Feed this card to Wolfram Intelligence
Download the M306T PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.